GOVERNANCE

Redwood Green is led by an extremely experienced and talented group of individuals who offer varying perspectives based on their diverse backgrounds and skill sets, as noted in their bios. From our corporate officers to our independent board of directors to our consultants who contribute specific talent necessary to successfully building out the company’s projects, the company is well-situated for future growth.

MANAGEMENT

Michael Saxon

Michael Saxon

CEO and Director

Michael Saxon is an accomplished consumer products executive with over 25 years of experience growing F100 businesses in the USA, Europe and Asia. He brings a strong innovative mindset from his experience creating new products and brands, and he has been the catalyst for successful large-scale transformation initiatives to drive organic growth and executing M&A transactions to enter new markets.

Mr. Saxon previously was the CEO of SXN Strategy Partners, which he founded in 2017 in Richmond, VA to advise primarily private equity firms on growth strategies and execution plans. That same year Michael helped build Trolley Ventures, Richmond’s only seed-round institutional venture capital firm.

His extensive international experience came from expat assignments in Central/ Eastern Europe, Taiwan, Malaysia and Scandinavia with Philip Morris International (PMI). Each market presented different go-to-market models and challenging regulatory environments. His international experience culminated in a CEO role in Scandinavia.

After his years abroad with PMI, Mr. Saxon returned to the U.S. in 2012 to work with Altria Group. He initially ran Altria Ventures Inc., then moved back into a general management role with P&L responsibility of Altria’s second largest business with $3.5B in revenue.

He graduated from the University of Georgia with a Bachelor in Business Administration with a major in Marketing. He is also on the board of Special Olympics Virginia.

Blair Mullin

Blair Mullin

CFO

(Philip) Blair Mullin is managing director of Somerset Associates LLC, a CFO, accounting, tax and financial consulting company, and serves on the board of CanaQuest Medical Corp. He has 30 years’ experience as CFO, COO, and in consulting and turnarounds for businesses with revenues of less than $100 million.

Since 2009, he has operated primarily in consulting and interim CFO roles in multiple sectors including fintech, blockchain, drones, recycling, medical marijuana, and electrical power generation. From 2003-09, Blair was a partner of Tatum Partners, a human capital firm engaged in providing CFO services. Within Tatum, Blair served in numerous leadership roles: from 2006-09, as CFO of Zi Corporation, a leading software development company specializing in mobile phones, which was sold in April 2009 to Nuance Communications; from 2003-06, as interim CFO of Homax Products, Vice President Finance of Yakima Products, and as a consultant in several engagements in industrial construction, manufacturing and air transportation; from 2001-03, as turnaround consultant to companies in the telecom sector during the critical post-9/11 timeframe; from 1995-2001, he was engaged in various C-level capacities in a public entity that was restructured and eventually became International DisplayWorks, a manufacturer of LCD displays based in Rocklin, California with operations in Shenzhen, China, which was later sold to Flextronics.

Mr. Mullin began his career in banking in 1982 after completing his MBA from University of Western Ontario Richard Ivey School of Business in London, Ontario, Canada and BA in Economics from Wilfrid Laurier University.  He currently resides in the Charlotte, North Carolina area.

Joe Galda

Joe Galda

Corporate Counsel

Joseph P. Galda is an experienced securities attorney with an entrepreneurial approach. He has a large cross-border practice and over the course of his career has had clients in 19 countries. Currently, he is the most active OTC Markets sponsor having sponsored 68 companies in 2018.

Mr. Galda opened his private practice, JPGalda & Co., in Ardmore, Pennsylvania in 2013. He was previously counsel with Fox Rothschild LLP as a Member of the Technology and Venture Finance Group based in the firm’s Exton office.  As president and founder of Corsair Advisors, Inc. he offered venture capital and corporate advisory services from 2004 through 2011. He was a partner with Hodgson Russ LLP from 2000 to 2004, based in Toronto, where he headed the firm’s cross-border securities practice and from 1996 to 2000 was with Buchanan Ingersoll & Rooney PC where he was a Member of the Corporate Finance Department and Technology and Corporate Control Practice Groups, with additional focus in cross-border transactions. Mr. Galda began his legal career with Drinker Biddle and Reath (1986-1990) and with Clark Ladner Fortenbaugh & Young (1990-1996).

Joe received his JD from Rutgers University School of Law – Camden after earning a BA in Economics from Rutgers – Camden.

BOARD OF DIRECTORS

Dr. Delon Human

Dr. Delon Human

Chairman of the Board

Dr. Delon Human, M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBA is a recognized global health leader, published author,  lecturer and healthcare consultant specializing in global health strategy, corporate and product transformation, harm reduction, access to healthcare and health communication. He is president of Health Diplomats, a specialized health, nutrition and wellness consulting group operating worldwide with clients including Fortune 500 companies, foundations, governments and NGOs such as the World Medical Association, World Dental Federation and the International Food and Beverage Alliance (IFBA).

He has acted as adviser to the WHO Director-General and to UN Secretary-General Ban Ki Moon. Until 2014, he served as Secretary-General and Special Envoy to WHO / UN of the International Food and Beverage Alliance, a group of leading food and non-alcoholic beverage companies with a global presence. For eight years, Dr. Human was secretary general of the World Medical Association (WMA) where he worked closely with the American Medical Association, WHO and FDA leadership involved in research ethics. He was instrumental in the establishment of the World Health Professions Alliance. In 2006 he was elected Secretary-General of the Africa Medical Association (AfMA). He is a fellow of the Russian and Romanian Academies of Medical Sciences.

Dr. Human was a clinician for two decades, part of the pediatric endocrinology research unit at the John Radcliffe Hospital and was involved in the establishment of several medical centers, a hospital and an emergency clinic in South Africa. Concurrently, he established a healthcare insurance company, Human Health Care, which provided strategic planning, medical audits and consumer care services to around 250,000 insured clients of several health funds. Dr. Human qualified as a physician in South Africa and completed his postgraduate studies in family medicine and child health in South Africa and Oxford, England. His business studies (MBA) were completed at the Edinburgh Business School.

Mario Gobbo

Mario Gobbo

Director

Mario Gobbo has 35 years of banking and corporate finance experience in healthcare and energy. His expertise encompasses venture capital and private equity as well as investment banking and strategic advisory services. He serves on the Supervisory Board of Cinkarna Celje, a fine chemicals company from Slovenia. He is on the board of Zavarovalnica Triglav, the largest Slovene insurance company spearheading healthcare insurance in Central Europe and was Chairman of the Board and Chair of the Audit Committee of Helix BioPharma, a Toronto-listed biotech company developing interesting novel complex biomolecules to combat various cancers.  As an executive director, he was also on the board of Lazard Brothers, London.

While Managing Director for Health Care Capital Markets and Advisory with Natixis Bleichroeder in New York, from 2006 to 2009, he secured transactions for the bank’s M&A and equity capital markets pharmaceuticals and life sciences group. He obtained mandates for several IPOs and follow-on transactions on NASDAQ, as well as advisory assignments for health care and medical devices companies. When with the International Finance Corporation, a World Bank Group institution dealing with private sector investments, the team he led completed several highly successful equity and loan investments in biotech and generic pharmaceutical companies and funds in India, Latin America, China and Central Europe. From 1993 to 2001, he was with Lazard in London, where he created and managed their Central and Eastern European operations, including Turkey. Mr. Gobbo advised on M&A, fundraising and privatization efforts for several key firms in the region, including transactions for the pharmaceutical companies Pliva, Bosnalijek, Lek and Krka and investments in the APDC Biotech fund, now renamed VentureEast, one of the first Indian life sciences funds, and BVCF, a highly successful and innovative healthcare fund in China.  Prior to Lazard, he worked with Swiss Bank Corporation International Ltd. in London, where he worked on the IPO of Ares Serono, the Swiss biotech company, subsequently sold to Merck KgaA.  He was also on the investment committee of AHF, an India focused health care fund, Ocimum Biosolutions/Genelogic, an Indian contract research organization, and CellPraxis, a US/Brazilian stem cell research, privately owned firm.

Mario Gobbo holds a Bachelor of Arts in Organic Chemistry from Harvard College, a Master of Science in Biochemistry from the University of Colorado and an MBA, a Master of Business Economics and a PhD (Management) from the Wharton School of the University of Pennsylvania.

Chris Hansen

Chris Hansen

Director

Christopher Hansen is a senior agriculture, finance and small and medium sized enterprise (SME) expert with more than 25 years of experience, primarily in the US, Latin America and Africa. Mr. Hansen is the founding CEO of Redwood Green Corp., a company focused on the development of high-value brands for the CBD cannabis sector. He was also the founding CEO of PharmaCielo Ltd., a leading producer of medicinal cannabis in Medellín, Colombia. He has led numerous successful initiatives on behalf of the Inter-American Institute for Cooperation on Agriculture (IICA), United States Agency for International Development (USAID), the International Finance Corporation (IFC/World Bank), the GIC Group, and the Swiss Foundation for Sustainable Development in Latin America (FUNDES).

Mr. Hansen’s expertise includes developing dynamic boards and management teams, corporate strategy development and implementation, identifying and negotiating collaborative agreements with market partners with the inclusion of individual farmers and other small local players, working with legislators, politicians and regulatory authorities to facilitate enabling political environments for newly developing industries such as the cannabis market.

He has served on numerous boards including the Tropical Agricultural Research and Higher Education Center (CATIE), Fondo Activo de Capital de Bolivia, a US$10 million private equity fund, Profund International, a US$23.0 million micro-finance fund focused on Latin America, and others. Mr. Hansen received a B.A. in Political Science from the University of California-Berkeley, attended the UC-Berkeley Haas School of Business, and began his studies in pre-law at Willamette University in Salem, Oregon.

Mark Radke

Mark Radke

Director

Mark Radke is a lawyer with a distinguished career in the area of financial services, specializing in federal securities regulation. As the Chief of Staff of the Securities and Exchange Commission under Chairman Harvey Pitt, he was responsible for that agency’s rulemaking in response to the Sarbanes Oxley Act. In private practice, as partner at several multinational law firms, he has represented corporations, brokerage and accounting firms, hedge funds and individuals on corporate governance, compliance, and regulatory issues involving not only the SEC but other federal and state regulators.

He was active in advising clients on legislative initiatives that lead to the Dodd-Frank Act of 2010, and in subsequent efforts to extend, implement or amend various components of that and other federal securities legislation.

Based in the Washington, D.C. area, Mr. Radke has advised political action committees and other entities in past election cycles. As an adjunct professor at the Georgetown University Law Center, he has taught classes in aspects of securities regulation since 1999. He holds a B.A. from the University of Washington, J.D. from the University of Baltimore and LL.M., Securities Regulation from Georgetown University Law Center.

Michael Saxon

Michael Saxon

Director

Michael Saxon is an accomplished consumer products executive with over 25 years of experience growing F100 businesses in the USA, Europe and Asia. He brings a strong innovative mindset from his experience creating new products and brands, and he has been the catalyst for successful large-scale transformation initiatives to drive organic growth and executing M&A transactions to enter new markets.

Mr. Saxon previously was the CEO of SXN Strategy Partners, which he founded in 2017 in Richmond, VA to advise primarily private equity firms on growth strategies and execution plans. That same year Michael helped build Trolley Ventures, Richmond’s only seed-round institutional venture capital firm.

His extensive international experience came from expat assignments in Central/ Eastern Europe, Taiwan, Malaysia and Scandinavia with Philip Morris International (PMI). Each market presented different go-to-market models and challenging regulatory environments. His international experience culminated in a CEO role in Scandinavia.

After his years abroad with PMI, Mr. Saxon returned to the U.S. in 2012 to work with Altria Group. He initially ran Atria Ventures Inc., then moved back into a general management role with P&L responsibility of Altria’s second largest business with $3.5B in revenue.

He graduated from the University of Georgia with a Bachelor in Business Administration with a major in Marketing. He is also on the board of Special Olympics Virginia.

John Scharffenberger

John Scharffenberger

Director

John Scharffenberger is a consultant to the farming and food production industry, offering a wide range of programs and services including agronomic analysis, product development, management and marketing to help both for-profit and non-profit producers sustainably increase returns. His clients have included Hodo Soy, Farmhouse Culture, Tout Sweets Patisserie, Front Porch Farms, Kaia Foods and Daylesford Organics among others. Prior to establishing his consultancy, he developed companies that combined agronomic innovation, sustainable production technologies and international brand development in the wine, chocolate and forestry industries, including Scharffenberger Cellars and the first artisanal chocolate company in the U.S., Scharffen Berger Chocolate Maker.

An avid gardener and amateur forester, he devotes substantial time to learning about food production processes on his 350-acre ranch in Mendocino County. He believes that a comprehensive study of cultural, historic and environmental contexts is the proper basis to achieve sustainable and successful food production.

Mr. Scharffenberger received a BA in Agricultural Geography from University of California, Berkeley in 1973. He served as Entrepreneur-in-Residence at London Business School in 2007 and has recently spoken at UC Berkeley commencement ceremonies, Brown University, and various symposia relating to small food production. Mr. Scharffenberger serves as trustee on the UC Berkeley College of Natural Resources advisory board, as a board member of Save the Redwoods League and is an emeritus advisory board member of the UC Berkeley Botanical Gardens.

Audit Committee

Mario Gobbo, Chair & Mark Radke

Nominating and Governance Committee

Mark Radke, Chair & Mario Gobbo

Compensation Committee

Dr. Delon Human, Chair, Mark Radke & John Scharffenberger

GOVERNANCE DOCUMENTS

CODE OF ETHICS

PRESS & COMMUNICATIONS
  • Redwood Green Corp. Announces Filing of 10-K, First Revenues and Unit Operating Profit
    – April 3, 2020 – Read more.
  • Corporate Update From Redwood Green Corp.’s CEO Michael Saxon
    – March 23, 2020 – Read more.
  • Shareholder Communication
    – March 5, 2020 – Read more.
  • Redwood Green Corp. Appoints Michael Saxon as CEO, Director
    – February 26, 2020 – Read more.
  • Redwood Green Corp. Appoints Dr. Delon Human as Board Chairman, Faun Chapin as New Director
    – December 20, 2019 – Read more.
  • Redwood Green Corp. Announces Stock Ticker Symbol Change to RDGC
    – November 15, 2019 – Read more.
  • First Colombia Development Corp. Announces Company Name Change to Redwood Green Corp., Board Confirmation of Strategic Plan, New Website and Headquarters
    – September 20, 2019 – Read more.
  • First Colombia Development Corp. Appoints Recognized Global Health Leader Dr. Delon Human to Board of Directors
    – August 14, 2019 – Read more.
  • First Colombia Development Corp. Announces Completion of Good Meds Acquisition, Moving Company Into Further Growth, Revenue Generation
    – August 7, 2019 – Read more.
  • First Colombia Development Corp. Closes Oversubscribed Financing for Gross Proceeds of US $7.7 Million
    – August 6, 2019 – Read more.
  • First Colombia Development Corp. Appoints Two New Directors: Mark Radke and John Scharffenberger
    – July 30, 2019. – Read more.
  • First Colombia Development Corp. Appoints Mario Gobbo to Board of Directors
    – July 9, 2019 – Read more.
  • First Colombia Development Corp. Appoints Blair Mullin as Chief Financial Officer
    – June 25, 2019 – Read more.
  • First Colombia Development Corp. Announces Acquisitions, Change in Strategy and Proposed New Financing
    – May 14, 2019 – Read more.

Media Contact

media@redwoodgreencorp.com

REGULATORY FILINGS

All of Redwood Green’s regulatory filings, including financial filings, are available at EDGAR, here: SEC CIK# 0001533030




*Before changing the company name to Redwood Green Corp. in September 2019, and previously First Colombia Development Corp. in April 2018, the company was named AFC Building Technologies Inc. and originally Auto Tool Technologies Inc. It was assigned SIC code 3420, “Cutlery, handtools & general hardware,” which will be updated in early 2020.

Company’s State location: CO | State of Inc.: NV | Fiscal Year End: 12/31

Formerly: FIRST COLOMBIA DEVELOPMENT CORP. (filings through 9-23-2019)
Formerly: AFC BUILDING TECHNOLOGIES INC. (filings through 5-02-2018)
Formerly: AUTO TOOL TECHNOLOGIES INC. (filings through 12-24-2013)

INVESTOR FAQS

Where is Redwood Green’s corporate headquarters?

Redwood Green’s principal offices are in Denver, CO. Our mailing address is 3531 South Logan Street, Suite D-357, Englewood, CO 80113

Is Redwood Green publicly traded, and on what exchange?

Yes. Redwood Green trades on the U.S. OTC market under the ticker symbol “RDGC”. Redwood Green common shares may be purchased through your online brokerage account or through your registered investment broker.

Can shares of Redwood Green be purchased directly from the company?

Shares of Redwood Green Corp. cannot be purchased directly from the company.

Does RDGC pay a dividend?

RDGC does not pay a dividend on its stock.

Where can I review Redwood Green’s regulatory filings?

All of Redwood Green’s regulatory filings can be reviewed at EDGAR, by searching on the name Redwood Green or inputting our SEC CIK# 0001533030. Additionally, our filings are posted at RedwoodGreenCorp.com in the Investors section.

Who is Redwood Green’s transfer agent?

Transhare is RDGC’s transfer agent and registrar for the common shares. Transhare’s Director of Operations Kim Whiteside can be reached at kwhiteside@transhare.com; (303) 662-1112; 2849 Executive Dr, Ste 200, Clearwater, FL 33762, USA.

How can I update my address, transfer my shares, request shareholder docs or replacement certificates?

If you are a registered stockholder with questions about your holdings or need to make changes to the account, please contact Redwood Green Corp.’s transfer agent, Transhare: kwhiteside@transhare.com, (303) 662-1112, or at 2849 Executive Dr, Ste 200, Clearwater, FL 33762, USA. Please contact the broker responsible for your account if you own shares through a brokerage account.

Who may I contact with shareholder or investing questions?

Please contact Redwood Green Corp.’s Investor Relations Director Jérémie St-Pierre: investors@redwoodgreencorp.com or +1 303 222 8092 (toll free at +1 833 817 7185)

INVESTOR CONTACT

investors@redwoodgreencorp.com

 

Subscribe now, and be among the first to receive Company News & Updates as developments are announced.

 

Yes, I want to receive News & Updates emails from Redwood Green Corp. (formerly First Colombia), which are usually sent no more than once a week. I understand I may unsubscribe at any time using the link provided in all Company News & Updates communications.

 

You have Successfully Subscribed!